2 recruiting, 1 completed. 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Progressive Nonfluent Aphasia: new trials by email Literature Review of Progressive Nonfluent Aphasia trials Research Report on Progressive Nonfluent Aphasia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Swedish BioFINDER 2 Study Flutemetamol F18 Injection, [18F]-RO6958948, Elecsys (Roche) Abeta42, Ttau and Ptau - Dementia, Alzheimer Disease | Not applicable | Recruiting | Skane University Hospital | 2950 | 2017-05-15 | 2026-04-06 |
| Diagnosing Frontotemporal Lobar Degeneration Observational Study - Corticobasal Syndrome, Progressive Supranuclear Palsy | Recruiting | University Health Network, Toronto | 100 | 2015-08-01 | 2025-03-30 | |
| Davunetide (AL-108) in Predicted Tauopathies - Pilot Study davunetide (AL-108, NAP), Placebo nasal spray - Predicted Tauopathies, Including, Progressive Supranuclear Palsy | Phase 1 | Completed | University of California, San Francisco | 12 | 2010-01-01 | 2019-04-05 |
Corticobasal Degeneration (3) · Frontotemporal Dementia (3) · Primary Progressive Nonfluent Aphasia (3) · Supranuclear Palsy, Progressive (3) · Alzheimer Disease (1) · Amyotrophic Lateral Sclerosis (1) · Cognitive Dysfunction (1) · Dementia (1) · Disease (1) · Frontotemporal Dementia With Motor Neuron Disease (1) · Frontotemporal Lobar Degeneration (1) · Lewy Body Disease (1) · Multiple System Atrophy (1) · Parkinson Disease (1) · Pick Disease of the Brain (1)
Aphasia (3) · Aphasia, Primary Progressive (3) · Basal Ganglia Diseases (3) · Brain Diseases (3) · Central Nervous System Diseases (3) · Communication Disorders (3) · Cranial Nerve Diseases (3) · Eye Diseases (3) · Language Disorders (3) · Mental Disorders (3) · Metabolic Diseases (3) · Movement Disorders (3) · Nervous System Diseases (3) · Neurobehavioral Manifestations (3) · Neurocognitive Disorders (3)
Observation (1) · davunetide (1)
Skane University Hospital (1) · University Health Network, Toronto (1) · University of California, San Francisco (1)
Canada (1) · Sweden (1) · United States (1)
Adam L. Boxer, M.D., Ph.D. (1) · Erik Stomrud, MD, Phd (1) · Maria C Tartaglia, M.D. (1)